These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 14625471

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.
    Ryan AE, Shanahan F, O'Connell J, Houston AM.
    Cancer Res; 2005 Nov 01; 65(21):9817-23. PubMed ID: 16267003
    [Abstract] [Full Text] [Related]

  • 6. Altered expression of membrane-bound and soluble CD95/Fas contributes to the resistance of fibrotic lung fibroblasts to FasL induced apoptosis.
    Bühling F, Wille A, Röcken C, Wiesner O, Baier A, Meinecke I, Welte T, Pap T.
    Respir Res; 2005 Apr 17; 6(1):37. PubMed ID: 15833141
    [Abstract] [Full Text] [Related]

  • 7. Endotoxemia enhances expression of the signaling receptor (GP130) on protein and molecular level.
    Marsik C, Halama T, Cardona F, Schlifke I, Mittermayer F, Jilma B.
    Clin Immunol; 2005 Mar 17; 114(3):293-8. PubMed ID: 15721840
    [Abstract] [Full Text] [Related]

  • 8. IL-1beta sensitizes rat intervertebral disc cells to Fas ligand mediated apoptosis in vitro.
    Cui LY, Liu SL, Ding Y, Huang DS, Ma RF, Huang WG, Hu BS, Pan QH.
    Acta Pharmacol Sin; 2007 Oct 17; 28(10):1671-6. PubMed ID: 17883956
    [Abstract] [Full Text] [Related]

  • 9. Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes.
    Brown SB, Savill J.
    J Immunol; 1999 Jan 01; 162(1):480-5. PubMed ID: 9886423
    [Abstract] [Full Text] [Related]

  • 10. Expression of Fas, FasL, and soluble Fas mRNA in endomyocardial biopsies of human cardiac allografts.
    Pérez EC, Shulzhenko N, Morgun A, Diniz RV, Almeida DR, Musatti CC, Gerbase-DeLima M.
    Hum Immunol; 2006 Jan 01; 67(1-2):22-6. PubMed ID: 16698421
    [Abstract] [Full Text] [Related]

  • 11. The breakdown of apoptotic mechanism in the development and progression of colorectal carcinoma.
    Ogawa S, Nagao M, Kanehiro H, Hisanaga M, Ko S, Ikeda N, Nakajima Y.
    Anticancer Res; 2004 Jan 01; 24(3a):1569-79. PubMed ID: 15274324
    [Abstract] [Full Text] [Related]

  • 12. Neither Fas ligand nor endotoxin is responsible for inducible peritoneal phagocyte apoptosis during sepsis/peritonitis.
    Chung CS, Song GY, Moldawer LL, Chaudry IH, Ayala A.
    J Surg Res; 2000 Jun 15; 91(2):147-53. PubMed ID: 10839964
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia.
    Spiel AO, Firbas C, Mayr FB, Leitner JM, Schmidt B, Knöbl P, Varadi K, Jilma B.
    Thromb Haemost; 2005 Dec 15; 94(6):1148-55. PubMed ID: 16411386
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. FAS/FAS ligand ratio: a marker of oxaliplatin-based intrinsic and acquired resistance in advanced colorectal cancer.
    Nadal C, Maurel J, Gallego R, Castells A, Longarón R, Marmol M, Sanz S, Molina R, Martin-Richard M, Gascón P.
    Clin Cancer Res; 2005 Jul 01; 11(13):4770-4. PubMed ID: 16000573
    [Abstract] [Full Text] [Related]

  • 17. Augmentation of Fas ligand-induced apoptosis by MUC1 mucin.
    Chaturvedi R, Srivastava RK, Hisatsune A, Shankar S, Lillehoj EP, Kim KC.
    Int J Oncol; 2005 May 01; 26(5):1169-76. PubMed ID: 15809706
    [Abstract] [Full Text] [Related]

  • 18. Altered expression of Fas receptor on alveolar macrophages and inflammatory effects of soluble Fas ligand following blunt chest trauma.
    Seitz DH, Palmer A, Niesler U, Braumüller ST, Bauknecht S, Gebhard F, Knöferl MW.
    Shock; 2011 Jun 01; 35(6):610-7. PubMed ID: 21330946
    [Abstract] [Full Text] [Related]

  • 19. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F.
    Cell Immunol; 2006 Feb 01; 239(2):121-8. PubMed ID: 16808908
    [Abstract] [Full Text] [Related]

  • 20. The role of Fas ligand and transforming growth factor beta in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy.
    Kim R, Emi M, Tanabe K, Uchida Y, Toge T.
    Cancer; 2004 Jun 01; 100(11):2281-91. PubMed ID: 15160330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.